Study on Evaluating the Effectiveness of Statins in the Treatment of Moyamoya Disease
NCT06817434 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 330
Last updated 2025-02-10
Summary
The purpose of this study is to investigate the effectiveness of statins in the treatment of moyamoya disease based on multimodal magnetic resonance imaging.
Conditions
- Moyamoya Disease
Interventions
- DRUG
-
Revascularization/Conservative management
Revascularization/Conservative management
Sponsors & Collaborators
-
Beijing Tiantan Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-15
- Primary Completion
- 2025-12-31
- Completion
- 2026-12-31
Countries
- China
Study Locations
More Related Trials
-
Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography
NCT06520904 ·Status: RECRUITING ·Phase: PHASE4
-
Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI
NCT01293097 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Acute Statin Treatment in Patients Undergoing Percutaneous Coronary Intervention
NCT00588471 ·Status: TERMINATED ·Phase: NA
-
Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome
NCT01372839 ·Status: UNKNOWN ·Phase: PHASE4
-
The Efficacy of Alirocumab for Thin-cap fIbroatheroma in Patients With Coronary Artery Disease Estimated by Optical Coherence Tomography
NCT03552432 ·Status: UNKNOWN ·Phase: PHASE4
-
Mechanism and Intervention Research of Atherosclerosis
NCT05437107 ·Status: COMPLETED
-
Impact of PCSK9 Inhibitors on Coronary Plaque Composition and Vulnerability Assessed by Optical Coherence Tomography
NCT04851769 ·Status: COMPLETED ·Phase: PHASE4
-
Statin Treatment for UnruptureD Intracranial anEurysms Study
NCT04149483 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effect of Statin Treatment on Arterial Wall Inflammation as Assessed With 68Ga-DOTATATE PET-CT
NCT05730634 ·Status: COMPLETED ·Phase: NA
-
Intensive Statin Treatment for STEMI Patients Undergoing Primary PCI
NCT01033058 ·Status: UNKNOWN ·Phase: PHASE4
-
Optimal Antiplatelet Therapy for Chinese Patients With Coronary Artery Disease
NCT01735305 ·Status: COMPLETED
-
A Study for Exploring the Efficacy of Naoxintong Capsules in the Treatment of Coronary Atherosclerotic Plaque on the Basis of Optimal Medical Therapy (Aspirin,Statins,Clopidogrel, Etc.): Stage One
NCT05278182 ·Status: UNKNOWN ·Phase: NA
-
Study on the Registration of Coronary Heart Disease Patients Undergoing PCI
NCT02888652 ·Status: COMPLETED
-
Interaction of Statins and Nondepolarizing Muscle Relaxants
NCT02222519 ·Status: UNKNOWN
-
Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS)
NCT06080256 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Atorvastatin for Preventing Occlusion and Restenosis After Intracranial Artery Stenting
NCT01255852 ·Status: COMPLETED ·Phase: PHASE4
-
Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds
NCT05589454 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Hepatic Safety of Statin Use in Neurology Inpatients
NCT06592196 ·Status: RECRUITING
-
Effect of Intensive Lipid-Lowering Therapy on Coronary Atherosclerotic Plaque Progression in Young and Middle-Aged Patients With Chronic Coronary Syndrome
NCT06896708 ·Status: RECRUITING ·Phase: NA
-
The Acute Effect of Statins on Inflammatory Markers of Athersclerotic Tissue
NCT00587717 ·Status: COMPLETED ·Phase: NA
-
The Clinical Effect of Intensive Statin Therapy in STEMI Patients Before Emergency PCI
NCT01334671 ·Status: UNKNOWN ·Phase: PHASE3
-
PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI
NCT05457582 ·Status: RECRUITING ·Phase: NA
-
Atorvastatin Mitigates WMH-Related Cognitive Impairment by Reducing VCAM-1
NCT07128212 ·Status: COMPLETED ·Phase: NA
-
Ezetimibe and Atorvastatin Therapy on TCFA
NCT02588235 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Intensive Statin Treatment on Left Ventricular Function
NCT01936103 ·Status: UNKNOWN ·Phase: PHASE4